NEW DELHI: The lockdown due to the novel coronavirus (Covid-19) outbreak has severely hampered the supply of anti-tuberculosis (TB) drugs to the central governments National TB Elimination Programme (NTEP), prompting the health ministry to recommend a ban on export of these drugs.
Leading anti-TB drugs manufacturers Macleods and Lupin — with factories at Ankleshwar and Bharuch in Gujarat, Baddi in Himachal Pradesh and Daman in Daman and Diu — have written to the health ministry highlighting that in view of the emergency measures undertaken, availability of manpower and material to the pharmaceutical industry is limited, affecting their Read More – Source
NEW DELHI: The lockdown due to the novel coronavirus (Covid-19) outbreak has severely hampered the supply of anti-tuberculosis (TB) drugs to the central governments National TB Elimination Programme (NTEP), prompting the health ministry to recommend a ban on export of these drugs.
Leading anti-TB drugs manufacturers Macleods and Lupin — with factories at Ankleshwar and Bharuch in Gujarat, Baddi in Himachal Pradesh and Daman in Daman and Diu — have written to the health ministry highlighting that in view of the emergency measures undertaken, availability of manpower and material to the pharmaceutical industry is limited, affecting their Read More – Source
